首页> 外国专利> Novel HCV core + 1 protein, HCV infection diagnosis method, prevention method and anti-HCV agent screening method

Novel HCV core + 1 protein, HCV infection diagnosis method, prevention method and anti-HCV agent screening method

机译:新型HCV核心+1蛋白,HCV感染诊断方法,预防方法和抗HCV药物筛选方法

摘要

The present invention relates to a novel form of core+1 protein of Hepatitis C virus (HCV), designated shorter form core+1 protein. The shorter form core+1 protein of Hepatitis C virus is the product of translation of a coding sequence consisting of all or part of a nucleotide sequence extending from nucleotide 598 to nucleotide 920 within the core+1 ORF of HCV represented on FIG. 3B. The invention also provides methods for detecting infection by Hepatitis C virus in biological samples, methods of screening compounds which interact with viral propagation in HCV infected cells or screening of compounds impaction on the expression of shorter form core+1 protein and uses of these compounds for the preparation of compositions useful for their anti-viral activities.
机译:本发明涉及丙型肝炎病毒(HCV)的核心+1蛋白的新形式,称为较短形式的核心+1蛋白。丙型肝炎病毒的较短形式的core + 1蛋白是编码序列的翻译产物,该编码序列由图9所示的HCV的core + 1 ORF内从核苷酸598延伸至核苷酸920的核苷酸序列的全部或部分组成。 3B。本发明还提供了用于检测生物样品中的丙型肝炎病毒感染的方法,筛选与在HCV感染的细胞中的病毒繁殖相互作用的化合物或筛选对较短形式的core + 1蛋白表达有影响的化合物的方法,以及这些化合物的用途。用于其抗病毒活性的组合物的制备。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号